OpenURL Connection Search

Select item for more details and to access through your institution.

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients.
Published in:
Cancers, 2024, v. 16, n. 8, p. 1487, doi. 10.3390/cancers16081487
By:
- Quagliariello, Vincenzo;
- Berretta, Massimiliano;
- Bisceglia, Irma;
- Giacobbe, Ilaria;
- Iovine, Martina;
- Giordano, Vienna;
- Arianna, Raffaele;
- Barbato, Matteo;
- Izzo, Francesca;
- Maurea, Carlo;
- Canale, Maria Laura;
- Paccone, Andrea;
- Inno, Alessandro;
- Scherillo, Marino;
- Gabrielli, Domenico;
- Maurea, Nicola
Publication type:
Article
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.
Published in:
Cancer Diagnosis & Prognosis, 2023, v. 3, n. 1, p. 44, doi. 10.21873/cdp.10178
By:
- ROMANO, FRANCESCO JACOPO;
- RONGA, RICCARDO;
- AMBROSIO, FRANCESCA;
- ARUNDINE, DARIO;
- LONGO, VITO;
- GALETTA, DOMENICO;
- GRIDELLI, CESARE;
- MAIONE, PAOLO;
- PALMA, VALENTINA;
- DAMIANO, VINCENZO;
- VERDE, ANTONIO;
- GIACOBBE, ILARIA;
- AUGURIO, MARIA ROSARIA;
- IENGO, GENNARO;
- CHETTA, MASSIMILIANO;
- TARSITANO, MARINA;
- CAMPIONE, SEVERO;
- FAILLA, GIUSEPPE;
- RAUCCI, ANTONIO;
- RICCARDI, FERDINANDO
Publication type:
Article
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11299, doi. 10.3390/ijms252011299
By:
- Quagliariello, Vincenzo;
- Canale, Maria Laura;
- Bisceglia, Irma;
- Iovine, Martina;
- Giordano, Vienna;
- Giacobbe, Ilaria;
- Scherillo, Marino;
- Gabrielli, Domenico;
- Maurea, Carlo;
- Barbato, Matteo;
- Inno, Alessandro;
- Berretta, Massimiliano;
- Tedeschi, Andrea;
- Oliva, Stefano;
- Greco, Alessandra;
- Maurea, Nicola
Publication type:
Article

Found: 3

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients.

Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.

Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients.